Ostoform News

Ostoform Limited today announce that Advances in Skin & Wound Care has published results of a third clinical study which evaluates the Ostoform Seal with FLOWASSIST Protection for individuals with an ileostomy. In the trial of 20 participants, 35% experienced an improvement in skin condition, 55% experienced no change in skin condition and 10% experienced …

Ostoform Clinical Study Published in Advances in Skin & Wound Care Read More »

Ostoform exhibited in the US for the first time at the national Wound, Ostomy and Continence Nurse Society’s annual conference, held in Nashville Tennessee. While attendees may have been enjoying some wonderful country music in the evenings, during the day, Ostoform’s exhibition booth was crowded with clinicians who were keen to hear more about the …

Ostoform Experiences Overwhelming Interest from Clinicians at WOCNext. Read More »

Ostoform is delighted to announce that a second clinical study using the Ostoform Seal with FLOWASSIST Protection has been published in the prominent Wound Management and Prevention Journal. This was a pilot study, which demonstrated encouraging results and positive user feedback. To read the Abstract, click here To read the full Article, click here

Ostoform is delighted to announce that it has closed a funding round of €1.1m. Investors include HBAN MedTech Angel Investment Syndicate, SOS Ventures and some experienced Medtech entrepreneurs. The funds will enable the company to finalise its product range and expand internationally. To read the full article, click here.

Ostoform is proud to announce the publication of a clinical study in the highly respected Journal of Wound Ostomy & Continence Nursing. “A wonderful accolade and fantastic recognition”, stated Ostoform’s CEO, Kevin Kelleher. The study demonstrates a statistically significant improvement in skin condition for a cohort of participants who have an ileostomy. User feedback was …

Ostoform Clinical Study Published in JWOCN Read More »

Through the Horizon 2020 SME Instrument, has identified Ostoform as a business with major potential for innovation and market impact. The European Commission has awarded the company funding of €50K to progress with its product development and device commercialisation. To read the full Article, click here

Ostoform is delighted to announce that the company has been selected as one of the winners in the UK-Ireland Headstart Proof-of-Concept Awards recently held at Oxford University. Kevin Kelleher CEO stated that “this is a compelling recognition of our work to date”. To read the full article, click here

The future looks exciting for Ostoform as it wins the Irish Times/AIB start-up Academy prize valued at €200,000. Winning this highly competitive contest enables the company to build an effective commercialisation strategy and to take the necessary steps for successful market launch.  “This is exactly what we need to build a relationship with the end …

Ostoform Wins Coveted Irish Times/AIB Start-Up Academy Read More »